Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin plus zinc vs azithromycin alone for mild to moderate acne vulgaris
IRCT20091012002581N12Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in acne vulgaris comparing Azithromycin plus zinc elemental with Azithromycin alone (2 arms). Started Mar 2024; status: completed.
02
Drugs
azithromycinzinc
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20091012002581N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002581N12.